Results 201 to 210 of about 66,239 (358)

Vascularized Tumor‐on‐a‐Chip Model as a Platform for Studying Tumor‐Microenvironment‐Drug Interaction

Macromolecular Bioscience, Volume 25, Issue 10, October 2025.
Vascularized tumor‐on‐a‐chip platforms replicate human tumor microenvironments by integrating perfusable vessels and stromal elements in microfluidic systems. These models enable dynamic assessment of drug delivery and therapeutic response under physiologically relevant flow, offering enhanced predictive value for cancer treatment.
Hyelim Kim, Seung‐Woo Cho, Hong Nam Kim   +2 more
wiley   +1 more source

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation [PDF]

, 2012
Peter C. Netzler
openalex   +1 more source

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 638-653, October 2025.
ABSTRACT Background There are sparse data to guide resumption of direct oral anticoagulants (DOACs) versus warfarin in patients with atrial fibrillation (AF) who survive a major gastrointestinal bleeding (GIB) event. Objective To compare the risk–benefit profile of restarting DOACs versus warfarin among patients with AF following hospitalization for ...
Oluwadolapo D. Lawal, Herbert D. Aronow, Fisayomi Shobayo, Yichi Zhang, Anne L. Hume, Tracey H. Taveira, Kelly L. Matson, Justin Gold, Xuerong Wen   +8 more
wiley   +1 more source

New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban

, 2008
Lars C. Borris
openalex   +2 more sources

Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report [PDF]

, 2012
Michael R. Boland, Maria Murphy, Marese Murphy, Enda McDermott   +3 more
openalex   +1 more source

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation

Acta Pharmacologica Sinica, 2022
Xiao-qin Liu, Yu-fei Zhang, H. Ding, Ming-Ming Yan, Z. Jiao, M. Zhong, Chun-Lai Ma   +6 more
semanticscholar   +1 more source

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 677-687, October 2025.
ABSTRACT Introduction Pediatric plastic bronchitis (PB) is a rare complication of surgically palliated congenital heart disease (CHD). Fibrin casts obstruct airways and can cause respiratory distress. There are no therapeutics approved by the United States Food and Drug Administration to treat PB, but inhaled tissue plasminogen activator (tPA) has been
Kathleen A. Stringer, David Goldberg, Sharon Chen, Philip Thrush, Eric M. Graham, Adam Lubert, Jeffrey Myers, Laura McLellan, Thomas Flott, Samya Nasr, Kurt R. Schumacher   +10 more
wiley   +1 more source

Orally Administered Factor Xa Inhibitor, Rivaroxaban

, 2008
Ricardo J. Komotar, Robert M. Starke, E. Sander Connolly   +2 more
openalex   +1 more source

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA): Table 1 [PDF]

, 2013
L. van Veen, Jos JAM van Raay, Carina L. E. Gerritsma-Bleeker, Nic J.G.M. Veeger, Marinus van Hulst   +4 more
openalex   +1 more source

Short-Term Postoperative Use of Rivaroxaban to Prevent Radial Artery Occlusion After Transradial Coronary Procedure: The RESTORE Randomized Trial

Circulation. Cardiovascular Interventions, 2022
Dongjie Liang, Qingcheng Lin, Qian-li Zhu, Xiao-Dong Zhou, Ying Fang, Liangguo Wang, Guangze Xiang, Kenneth I. Zheng, Weijian Huang, P. Shan   +9 more
semanticscholar   +1 more source